Table 2.
Medication of PROVIT sample at baseline (in alphabetical order).
| Intervention Group (N = 28) |
Placebo Group (N = 33) |
|||
|---|---|---|---|---|
| N | % | N | % | |
| Anticonvulsants | 3 | 10.7 | 3 | 9.1 |
| Atypical antipsychotics | 10 | 35.7 | 9 | 27.3 |
| Benzodiazepines and hypnotics | 5 | 17.9 | 7 | 21.2 |
| Glutamatergic antidepressants | 0 | 0.0 | 1 | 3.0 |
| Low potency antipsychotics | 1 | 3.6 | 7 | 21.2 |
| Melatonin-like antidepressants | 0 | 0.0 | 1 | 3.0 |
| Mixed preparation of antidepressant and antipsychotic | 1 | 3.6 | 0 | 0.0 |
| Noradrenergic and specific serotonergic antidepressants | 3 | 10.7 | 3 | 9.1 |
| Norepinephrine–dopamine reuptake inhibitor (NDRI) | 1 | 3.6 | 5 | 15.2 |
| Selective serotonin reuptake inhibitors (SSRIs) | 16 | 57.1 | 25 | 75.8 |
| Serotonin–norepinephrine reuptake inhibitors (SNRIs) | 7 | 35.0 | 12 | 36.4 |
| Tri- and tetracyclic antidepressants (TZA) | 0 | 0.0 | 2 | 6.1 |